Y Intercept Hong Kong Ltd Makes New Investment in Option Care Health, Inc. (NASDAQ:OPCH)

Y Intercept Hong Kong Ltd purchased a new stake in Option Care Health, Inc. (NASDAQ:OPCH) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 14,092 shares of the company’s stock, valued at approximately $327,000.

A number of other institutional investors and hedge funds also recently modified their holdings of OPCH. Wellington Management Group LLP increased its holdings in shares of Option Care Health by 15.5% in the 3rd quarter. Wellington Management Group LLP now owns 9,924,915 shares of the company’s stock worth $310,650,000 after acquiring an additional 1,328,326 shares during the period. FMR LLC grew its position in Option Care Health by 134.0% in the 3rd quarter. FMR LLC now owns 7,516,448 shares of the company’s stock valued at $235,265,000 after buying an additional 4,304,896 shares in the last quarter. Westfield Capital Management Co. LP boosted its position in shares of Option Care Health by 10.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company’s stock valued at $203,204,000 after purchasing an additional 599,589 shares in the last quarter. State Street Corp boosted its holdings in shares of Option Care Health by 1.4% in the third quarter. State Street Corp now owns 6,257,172 shares of the company’s stock worth $195,849,000 after buying an additional 83,395 shares during the period. Finally, Thrivent Financial for Lutherans increased its position in shares of Option Care Health by 7.4% in the third quarter. Thrivent Financial for Lutherans now owns 5,863,930 shares of the company’s stock worth $183,541,000 after acquiring an additional 404,811 shares in the last quarter. 98.05% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now owns 44,974 shares of the company’s stock, valued at $1,495,835.24. This represents a 40.80 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.64% of the stock is currently owned by corporate insiders.

Option Care Health Trading Up 1.4 %

Shares of Option Care Health stock opened at $33.96 on Tuesday. The stock has a market capitalization of $5.78 billion, a P/E ratio of 28.54, a price-to-earnings-growth ratio of 2.30 and a beta of 1.35. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The company has a 50-day simple moving average of $28.92 and a 200 day simple moving average of $28.07. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $34.57.

Wall Street Analysts Forecast Growth

OPCH has been the subject of several research reports. JMP Securities restated a “market outperform” rating and set a $30.00 price target (down from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and lifted their target price for the company from $26.00 to $33.00 in a research note on Monday, January 13th. Jefferies Financial Group upgraded shares of Option Care Health from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $26.00 to $35.00 in a research note on Thursday, January 23rd. JPMorgan Chase & Co. boosted their price objective on shares of Option Care Health from $38.00 to $40.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Finally, Barrington Research boosted their price objective on shares of Option Care Health from $33.00 to $38.00 and gave the stock an “outperform” rating in a research note on Thursday, February 27th. Two analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Option Care Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $32.88.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.